Reversing a longstanding policy, the US government said on Friday that human and other genes should not be eligible for patents. The new position could have a huge impact on medicine and on the biotechnology industry.
The new position was declared in a friend-of-the-court brief filed by the US Department of Justice late on Friday in a case involving two human genes linked to breast and ovarian cancer.
“We acknowledge that this conclusion is contrary to the longstanding practice of the Patent and Trademark Office, as well as the practice of the National Institutes of Health and other government agencies that have in the past sought and obtained patents for isolated genomic DNA,” the brief said.
It is not clear if the position in the legal brief, which appears to have been the result of discussions among various government agencies, will be put into effect by the Patent Office.
If it were, it is likely to draw protests from some biotechnology companies that say such patents are vital to the development of diagnostic tests, drugs and the emerging field of personalized medicine, in which drugs are tailored for individual patients based on their genes.
“It’s major when the United States, in a filing, reverses decades of policies on an issue that everyone has been focused on for so long,” said Edward Reines, a patent attorney who represents biotechnology companies.
The issue of gene patents has long been a controversial and emotional one. Opponents say that genes are products of nature, not inventions, and should be the common heritage of mankind. They say that locking up basic genetic information in patents actually impedes medical progress.
Proponents say genes isolated from the body are chemicals that are different from those found in the body and therefore are eligible for patents.
The Patent and Trademark Office has sided with the proponents and has issued thousands of patents on the genes of various organisms, including on an estimated 20 percent of human genes.
However, in its brief, the government said it now believed that the mere isolation of a gene, without further alteration or -manipulation, did not change its nature.
“The chemical structure of native human genes is a product of nature, and it is no less a product of nature when that structure is ‘isolated’ from its natural environment than are cotton fibers that have been separated from cotton seeds or coal that has been extracted from the earth,” the brief said.
However, the government suggested such a change would have limited impact on the biotechnology industry because man-made manipulations of DNA, like methods to create genetically modified crops or gene therapies, could still be patented.
James Evans, a professor of genetics and medicine at the University of North Carolina who headed a government advisory task force on gene patents, called the government’s brief “a bit of a landmark, kind of a line in the sand.”
He said that although gene -patents had been issued for decades, the patentability of genes had never been examined in court.
That changed when the American Civil Liberties Union and the Public Patent Foundation organized various individuals, medical researchers and societies to file a lawsuit challenging patents held by Myriad Genetics and the University of Utah Research Foundation. The patents cover two genes, BRCA1 and BRCA2, and the over US$3,000 analysis Myriad performs on the genes to see if women carry mutations that predispose them to breast and ovarian cancers.
In a surprise ruling in March, Judge Robert Sweet of the US District Court in Manhattan ruled the patents invalid. He said genes were important for the information they convey, and in that sense, an isolated gene was not really different from a gene in the body. The -government said that ruling prompted it to re-evaluate its policy.
Myriad and the University of Utah have appealed.
Saying that the questions in the case were “of great importance to the national economy, to medical science and to the public health,” the Justice Department filed an amicus brief that sided with neither party. While the government took the plaintiffs’ side on the issue of isolated DNA, it sided with Myriad on patentability of manipulated DNA.
Myriad and the plaintiffs did not comment on the government’s brief by deadline for this article.
Reines, who is with the firm of Weil Gotshal & Manges and is not involved in the main part of the Myriad case, said he thought the Patent Office opposed the new position, but was overruled by other agencies. A hint is that no lawyer from the Patent Office was listed on the brief.
In the sweltering streets of Jakarta, buskers carry towering, hollow puppets and pass around a bucket for donations. Now, they fear becoming outlaws. City authorities said they would crack down on use of the sacred ondel-ondel puppets, which can stand as tall as a truck, and they are drafting legislation to remove what they view as a street nuisance. Performances featuring the puppets — originally used by Jakarta’s Betawi people to ward off evil spirits — would be allowed only at set events. The ban could leave many ondel-ondel buskers in Jakarta jobless. “I am confused and anxious. I fear getting raided or even
Eleven people, including a former minister, were arrested in Serbia on Friday over a train station disaster in which 16 people died. The concrete canopy of the newly renovated station in the northern city of Novi Sad collapsed on Nov. 1, 2024 in a disaster widely blamed on corruption and poor oversight. It sparked a wave of student-led protests and led to the resignation of then-Serbian prime minister Milos Vucevic and the fall of his government. The public prosecutor’s office in Novi Sad opened an investigation into the accident and deaths. In February, the public prosecutor’s office for organized crime opened another probe into
RISING RACISM: A Japanese group called on China to assure safety in the country, while the Chinese embassy in Tokyo urged action against a ‘surge in xenophobia’ A Japanese woman living in China was attacked and injured by a man in a subway station in Suzhou, China, Japanese media said, hours after two Chinese men were seriously injured in violence in Tokyo. The attacks on Thursday raised concern about xenophobic sentiment in China and Japan that have been blamed for assaults in both countries. It was the third attack involving Japanese living in China since last year. In the two previous cases in China, Chinese authorities have insisted they were isolated incidents. Japanese broadcaster NHK did not identify the woman injured in Suzhou by name, but, citing the Japanese
RESTRUCTURE: Myanmar’s military has ended emergency rule and announced plans for elections in December, but critics said the move aims to entrench junta control Myanmar’s military government announced on Thursday that it was ending the state of emergency declared after it seized power in 2021 and would restructure administrative bodies to prepare for the new election at the end of the year. However, the polls planned for an unspecified date in December face serious obstacles, including a civil war raging over most of the country and pledges by opponents of the military rule to derail the election because they believe it can be neither free nor fair. Under the restructuring, Myanmar’s junta chief Min Aung Hlaing is giving up two posts, but would stay at the
RSS